MSL Retard Tablet 15 mg contains Morphine Sulfate, a potent opioid analgesic formulated for extended-release (retard) action. This formulation is designed to provide sustained pain relief over an extended period, reducing the need for frequent dosing. Morphine works by binding to opioid receptors in the central nervous system, modifying the perception and emotional response to pain, and providing both analgesic and sedative effects.
The extended-release formulation ensures continuous and stable plasma levels, making MSL Retard ideal for patients with chronic pain, cancer-related pain, or severe persistent pain, where long-lasting analgesia is required. This minimizes pain fluctuations and enhances patient comfort, mobility, and quality of life.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
MSL Retard Tablet 15 mg is indicated for:
Chronic moderate to severe pain, especially in patients requiring around-the-clock analgesia
Cancer-related pain in palliative care settings
Severe chronic musculoskeletal or neuropathic pain
Patients unresponsive to non-opioid analgesics such as NSAIDs or acetaminophen
Post-operative or post-traumatic pain where long-term pain control is needed
The extended-release nature makes it suitable for patients who require stable analgesia without frequent dosing, improving treatment adherence and convenience.
Recommended dosage:
Adults: Typically 15 mg every 12 hours, or as prescribed by a healthcare professional
Dose adjustment may be required for elderly patients, renal or hepatic impairment, or opioid-naïve individuals
Therapy should begin with the lowest effective dose and titrated to achieve adequate pain control
Administration guidelines:
Take the tablet whole with a full glass of water; do not crush, chew, or split, as this can release the drug too quickly and increase the risk of overdose
Can be taken with or without food
Avoid alcohol and other CNS depressants unless specifically approved by a physician
Regular, scheduled dosing helps maintain consistent pain control
Addiction, abuse, and dependence: Morphine has a high potential for habit formation; use under strict medical supervision
Respiratory depression: Risk is highest in opioid-naïve patients or when combined with other CNS depressants
Pregnancy and breastfeeding: May cause neonatal respiratory depression; use only if clearly necessary
Medical conditions: Exercise caution in patients with asthma, COPD, head injury, liver or kidney disease, or gastrointestinal obstruction
Drug interactions: Avoid combining with benzodiazepines, sedatives, or alcohol
Common side effects of MSL Retard Tablet 15 mg include:
Drowsiness, dizziness, or sedation
Constipation, nausea, or vomiting
Dry mouth, sweating, or mild hypotension
Rare: severe respiratory depression, allergic reactions, or hypotension
Most side effects are dose-dependent and manageable with monitoring and supportive care. Severe reactions require immediate medical attention.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep tablets in their original packaging and out of reach of children. Proper disposal of unused tablets is essential to prevent accidental ingestion or misuse.
MSL Retard Tablet 15 mg (Morphine Sulfate) provides sustained, effective pain relief for patients with chronic or severe pain, combining convenient dosing, stable analgesic levels, and improved patient comfort under medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet